July 19, 2013
A Virginia magistrate judge on Friday recommended that a U.S. Patent and Trademark Office appeal board decision rejecting Tact IP LLC's bid to claim priority for patents covering treatment for neurological conditions should be reversed, saying the disputed methods are novel and nonobvious.
August 16, 2012
Tact IP LLC on Wednesday filed a suit against Janssen Biotech Inc. and New York University that sought to overturn a recent U.S. Patent and Trademark Office appeal board decision that rejected Tact's bid to claim priority for patents covering treatment for neurological conditions.